Provided by Tiger Fintech (Singapore) Pte. Ltd.

China Pharma

1.61
+0.09306.12%
Post-market: 1.610.00000.00%19:58 EDT
Volume:78.19K
Turnover:123.59K
Market Cap:5.26M
PE:-0.59
High:1.70
Open:1.59
Low:1.46
Close:1.52
Loading ...

North China Pharmaceutical Gets Registration Certificate for Isavuconazonium Sulfate for Injection

MT Newswires Live
·
06 Jun

North China Pharmaceutical Signs Financial Services Deal With Jizhong Energy Group Finance

MT Newswires Live
·
22 May

US Stock Futures Slump Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern

Benzinga
·
07 Apr

Levi Strauss, Dave & Buster's Entertainment And 3 Stocks To Watch Heading Into Monday

Benzinga
·
07 Apr

China Pharma Holdings Announces Reverse Stock Split

TIPRANKS
·
05 Apr

BRIEF-China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split

Reuters
·
05 Apr

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

THOMSON REUTERS
·
05 Apr

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

PR Newswire
·
05 Apr

North China Pharmaceutical Secures EU GMP Certification

MT Newswires Live
·
13 Mar

North China Pharmaceutical Subsidiary Passes GMP Compliance Inspection

MT Newswires Live
·
25 Feb

Shyndec Pharma Gets China Pharmaceutical Ingredient Approval for Anaesthesia Supplementary Drug

MT Newswires Live
·
08 Jan

BRIEF-China Pharma Holdings And Investor Agree To Rescind Securities Purchase Agreement Dated December 12

Reuters
·
27 Dec 2024

China Pharma Holdings Inc - Co and Investor Agree to Rescind Securities Purchase Agreement Dated December 12

THOMSON REUTERS
·
27 Dec 2024

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement With Streeterville

THOMSON REUTERS
·
18 Dec 2024

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

PR Newswire
·
18 Dec 2024

North China Pharmaceutical Withdraws Drug Registration for Antibiotic

MT Newswires Live
·
17 Dec 2024

China Pharma Announces the Entry of "at-the-Market" Equity Offering

THOMSON REUTERS
·
13 Dec 2024

China Pharma Announces the Entry of "At-The-Market" Equity Offering

PR Newswire
·
13 Dec 2024